FLT1 and systemic lupus erythematosus: In addition, we examined the database presented by Ota et al. as well as other sources and discovered an elevated level of VEGFB or FLT1 expression within the CD4+ or CD8+ T cells obtained from individuals with immune-mediated disorders, such as diabetes, asthma, or SLE.